Steve Bernstein
Analyst · the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this conference call. It is now my pleasure to introduce your host for today, Martin Bloch, Executive Chairman of the Board of Frequency Electronics
Thank you, Stan. Good afternoon. For the six and three months ended October 31, 2019, consolidated revenue was $21.6 million and $9.1 million, compared to $23.2 million and $12.1 million, for the prior fiscal year. The components of revenue for the six-month period are as follows. Revenue from commercial and U.S. government satellite programs was $9.4 million, compared to $11.3 million for the same period of the prior fiscal year and accounted for approximately 44% of consolidated revenues compared to 49% for the same period of the prior fiscal year. Revenues on satellite payload contracts are recorded primarily under the percentage of completion method and are recorded only in the FEI-New York segment. Revenues from non-space U.S. government and DOD customers, which are recorded in both the FEI-New York and FEI-Zyfer segments are $9 million compared to $10.4 million in the previous fiscal year and accounted for approximately 42% of consolidated revenues, compared to 45% for the prior fiscal year. Other commercial industrial revenues was $3.2 million, compared to $1.4 million in the prior fiscal year. Inter-segment revenues are eliminated in consolidation. For the 6 and 3-month periods ended October 31, 2019, gross margin and gross margin rate decreased to $12.8% and negative 13% as compared to 35.8% and 33.1% for the same periods in fiscal 2019. The gross margin and gross margin rate was impacted by increases in engineering costs incurred on several programs, which in development phase and which encountered unanticipated development challenges related to customer-driven technical requirements. GAAP accounting requires that at the time a loss is anticipated on a contract that the entire estimated cost to complete is accrued at that time. In the quarter just ended, we had two development programs fall into this accounting, with an impact of recognizing approximately $4 million charge to cost of goods sold. For the 6 and 3 months period ended October 31, 2019, SG&A expenses decreased compared to the same periods in fiscal 2019. For the 6 months ended October 31, 2019 and 2018, selling and administrative expenses were approximately 22% of consolidated revenues for both periods. While SG&A expense remains even as a percentage of consolidated revenue, during the 6 months ending October 31, 2019 as compared to the 6 months ended October 2018, the actual dollar expenditures decreased by $439,000. Research and development expenditures represent investment intended to keep Company’s products at the leading edge of time and frequency technology and enhance future competitiveness. The R&D rate for the 6 months ending October 31, 2019 was 17% of sales compared to 14% of sales for the same period of the previous fiscal year. The R&D rate for the 3 months ended October 31, 2019 was 16% of sales, as compared to 13% of sales for the same period of the previous fiscal year. For the 6 and 3 months ending October 31, 2019, the Company recorded an operating loss of $5.7 million and $4.9 million, compared to $146,000 and $230,000 for the prior fiscal year. That change is largely attributable to the increasing engineering costs described previously. The increased cost affects gross margin and operating income. Other income consists primarily investment income derived from the Company's holdings of marketable securities. For the 6-month period ending October 31, 2019, other income included $125,000 dividend from Morion, compared to $105,000 dividend in the previous fiscal year. This yields a pre-tax loss for the 6 and 3 months period ended October 31, 2019 of approximately $5.5 million and $4.9 million compared to a pre-tax income of approximately $131,000 and $92,000 for the prior year. For the 6 months ending October 31, 2019, the Company recorded a tax provision of $29,000, compared to $23,000 tax benefit for the same period of fiscal 2019. For the six months ending October 31, 2019, consolidated net loss was $5.5 million or $0.61 per diluted share, compared to income of $153,000, or $0.02 per share for the same period of the previous fiscal year. For the three months ending October 31, 2019, consolidated net loss was $4.9 million or $0.54 per diluted share, compared to income of $122,000, or $0.01 per diluted share for the same period of the previous fiscal year. For the six-month period ending October 31, 2019, the Company generated positive cash flow from operations of approximately $180,000. Our fully funded backlog at the end of October 2019 was approximately $40 million, up approximately $5 million from the previous quarter. The Company's balance sheet continues to reflect a strong working capital position of approximately $40 million at October 31, 2019, debt free and a current ratio of over 5.9 to 1. The Company believes that its liquidity is adequate to meet its operations and investing needs for the next 12 months in the foreseeable future. I return the call back to Stan, and we look forward to your questions later.